MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Monitoring Parkinson’s Disease in the Dental Chair

    J. Schwartz, L. Dibenedetto, P. Engen, V. Ha, B. Killinger, C. Soto, S. Green, A. Naqvi, S. Tomar, M. Shaikh, M. Villanueva, D. Sanchez-Bass, C. Noh, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: Our goal is to bridge the mechanistic knowledge gap on the Microbiota-Gut-Oral-Brain-Axis (MGOBA)’s role in Parkinson’s disease (PD) pathogenesis through a case-control, proof-of-concept, observational…
  • 2025 International Congress

    iPad App-based Eye Tracking for the Early Detection of Parkinson’s Disease

    F. David, J. Koerner, E. Zou, J. Karl, C. Poon, C. Sodini, V. Sze, L. Verhagen-Metman, T. Heldt (Chicago, USA)

    Objective: Demonstrate the concurrent validity, diagnostic accuracy, and early detection ability of an iPad app-based eye tracking tool for the early detection of Parkinson’s disease…
  • 2025 International Congress

    Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson’s disease

    H. Oizumi, T. Hasegawa, I. Kawahata, T. Totsune, Y. Sugimura, T. Baba, H. Tanaka, T. Takahashi, M. Yoshioka, T. Sekimori, K. Fukunaga, A. Takeda (Sendai, Japan)

    Objective: The aim of the present study was to test whether plasma NF-L, FABP3, UCH-L1, and gray matter volumes can be used as prognostic biomarkers…
  • 2025 International Congress

    Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study

    MI. de Bartolo, D. Belvisi, E. Patricolo, M. Costanzo, C. Cutrona, F. Aiello, G. Leodori, A. Conte, G. Fabbrini, A. Berardelli, G. Vivacqua (Rome, Italy)

    Objective: Investigate longitudinal changes in salivary levels of oligomeric and total a-synuclein (a-syn), phosphorylated-tau (p-tau), total tau, MAP-LC3, and TNFa in Parkinson’s Disease (PD) patientsAssess…
  • 2025 International Congress

    Plasma neurofilament light chain in early Parkinson’ s disease predicts motor complications: A Prospective Cohort Study

    NN. Che (Chengdu, Sichuan, China)

    Objective: The current study aimed to identify risk plasma biomarkers in early-stage PD for future motor complications through a longitudinal Chinese PD cohort, which ultimately…
  • 2025 International Congress

    Prevalence and Management of Depression Among Parkinson’s Patient’s in an Outpatient Clinic Setting

    E. Parker, T. Siriwardena (Perth, Australia)

    Objective: To evaluate the prevalence of depression among Parkinson’s Disease (PD) patients attending an outpatient clinic and review current management to improve diagnosis and treatment…
  • 2025 International Congress

    Positive post-intervention effect of Biodanza therapy on inhibitory control related to the orbitomedial prefrontal cortex.

    M. Moreno, M. Aveiga, J. Guapisaca, G. Bueno, M. Pinos (CUENCA, Ecuador)

    Objective: A study was conducted to determine the effect of a Music-based-Movement (MbM) program on the physical and cognitive domains of a group of people…
  • 2025 International Congress

    Episodic Simulation in Parkinson’s Disease (PD)

    J. Decker, N. Hantke, E. Leonard (Portland, USA)

    Objective: Characterize episodic simulation capabilities in non-depressed, non-amnestic patients with PD compared to healthy controls using autobiographical interviewing techniques. Background: Cognitive decline in PD occurs…
  • 2025 International Congress

    The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

    E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

    Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific…
  • 2025 International Congress

    Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)

    Objective: To analyze the impact of anxiety on self-perception of health in patients with Idiopathic Parkinson's Disease Without Dementia. Background: After depression in Idiopathic Parkinson's…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 436
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley